New Products

READING, Mass. — Physicians Interactive, a provider of online and mobile clinical resources and solutions for healthcare professionals, and McKesson Patient Relationship Solutions, a provider of pharmaceutical manufacturer-sponsored patient adherence programs, on Tuesday announced a collaboration to jointly deliver Coupons on Demand. The new solution is designed to provide clinicians convenient access to medication cost-savings offers and adherence support through a patented web-based platform.  

JERUSALEM — Teva Pharmaceutical Industries announced the launch of Adasuve (loxapine) inhalation powder in a 10-mg dosage. The drug is the first and only orally inhaled medicine for the acute treatment of agitation associated with schizophrenia or bipolar disorder in adults.

CINCINNATI — Procter & Gamble’s Oral-B has announced the launch of an oral care app for children — the Disney Magic Timer App by Oral-B.

Created in collaboration with Disney and powered by DreamPlay, the oral care app is designed to helps kids increase brushing time, which is identified by dentists as an area of concern and improvement for children.

CINCINNATI and AIRPORT CITY, Israel — SodaStream, a manufacturer of home beverage carbonation systems, announced that it has entered into an agreement with Sunny Delight Beverages Co., a producer of juice-based drinks. The companies will co-develop flavors like SunnyD Tangy Original Orange and Orange-Strawberry exclusively for the SodaStream system.

BOSTON — Somersets, a line of shaving and skincare products from the United Kingdom, has announced a new retail partnership with Walgreens, beginning this month.

In support of the new distribution, Somersets will highlight Walgreens in promotional materials as well as a social media campaign. Products available at the launch locations include:


SIMI VALLEY, Calif. — Skin care company derma e has introduced its first sun care products — Antioxidant Natural Sunscreen SPF 30 Oil-Free Face Lotion and Body Lotion.
 

WILMINGTON, Del. — AstraZeneca received approval from the Food and Drug Administration for its Bydureon pen (exenatide extended-release for injectable suspension) 2-mg, which is to be used as an addition to diet and exercise to improve glycemic control in adults with Type 2 diabetes.

The Bydureon pen is a pre-filled, single-use pen injector, which eliminates the need for the patient to transfer their medication between a vial and syringe during the process of self-injection. The pen contains the same formula and dose as the original Bydureon single-dose tray.

NEW YORK — After a two-year hiatus, U.K.’s King of Shaves is back in action and ready to change the manscape of the industry with its new launch Hyperglide razor now available at Target and Target.com.